Anastasia Meis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anastasia Meis has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Christoph Fusch
Department of Pediatrics, Paracelsus Medical University, Breslauer Str. 201, 90471 Nürnberg, Germany
2 shared publications - Gisela Adrienne Weiss
Department of Pediatrics, Paracelsus Medical University, Breslauer Str. 201, 90471 Nürnberg, Germany
2 shared publications - Jasper L. Zimmermann
Department of Pediatrics, Paracelsus Medical University, Breslauer Str. 201, 90471 Nürnberg, Germany
2 shared publications - Julia Welsch
Department of Pediatrics, Paracelsus Medical University, Breslauer Str. 201, 90471 Nürnberg, Germany
2 shared publications - Katja Knab
Department of Pediatrics, Paracelsus Medical University, Breslauer Str. 201, 90471 Nürnberg, Germany
2 shared publications - Kerstin Simon
Department of Pediatrics, Paracelsus Medical University, Breslauer Str. 201, 90471 Nürnberg, Germany
2 shared publications
Latest Publications
- Open Access
Freeze-Dried Donor Milk for Fortification of Mother’s Own Milk in Preterm Infants: A Preliminary Observational Study
Background/Objectives: Freeze-dried high-temperature short-time pasteurized human milk fortifiers offer potential for exclusive human milk feeding in preterm infants while providing necessary nutritional supplementation. However, clinical data on safety, tolerability, and growth outcomes remain limited. This study evaluated donor milk fortification compared to conventional bovine protein-based fortification. Methods: We conducted a prospective non-interventional observational cohort study with a retrospectively matched comparison cohort at University Children’s Hospital of Nuremberg. Preterm infants ≥ 30 weeks gestational age requiring mother’s own milk fortification were included. The exposed cohort (n = 32) received freeze-dried high-temperature short-time pasteurized donor milk fortifier at 1.6–4.8 g/100 mL of mother’s own milk; the matched comparison cohort (n = 32) received bovine protein-based fortifier. Primary outcomes included feeding tolerance, safety parameters, and anthropometric measurements. Cohorts were matched for birth weight (±10%), gestational age (±5 days), and fortified feeding. Results: Baseline characteristics were not significantly different: gestational ages 32.8 ± 1.0 versus 33.0 ± 1.2 weeks; birth weights 1900 ± 380 g versus 1840 ± 370 g. Excellent feeding tolerance was demonstrated across >3100 feedings. No necrotizing enterocolitis, abdominal complications, or serious adverse events occurred. Blood glucose, triglycerides, and urea remained normal. Birth weights, lengths, and head circumferences showed no significant differences. Discharge parameters including weight, length, head circumference, and length of stay were also not significantly different. Conclusions: Freeze-dried human milk fortification demonstrates excellent safety and tolerability in preterm infants ≥ 30 weeks gestational age, achieving anthropometric outcomes not significantly different to bovine protein-based fortification. However, the suboptimal protein-to-energy ratio may limit applicability for very low birth weight infants. Therefore, freeze-dried high-temperature short-time pasteurized human milk fortification is suggested to provide appropriate nutritional supplementation for preterm infants with a birth weight over 1500 g.
Open AccessFreeze-Dried Donor Milk for Fortification of Mother’s Own Milk in Preterm Infants: A Preliminary Observational Study
Background/Objectives: Freeze-dried high-temperature short-time pasteurized human milk fortifiers offer potential for exclusive human milk feeding in preterm infants while providing necessary nutritional supplementation. However, clinical data on safety, tolerability, and growth outcomes remain limited. This study evaluated donor milk fortification compared to conventional bovine protein-based fortification. Methods: We conducted a prospective non-interventional observational cohort study with a retrospectively matched comparison cohort at University Children’s Hospital of Nuremberg. Preterm infants ≥ 30 weeks gestational age requiring mother’s own milk fortification were included. The exposed cohort (n = 32) received freeze-dried high-temperature short-time pasteurized donor milk fortifier at 1.6–4.8 g/100 mL of mother’s own milk; the matched comparison cohort (n = 32) received bovine protein-based fortifier. Primary outcomes included feeding tolerance, safety parameters, and anthropometric measurements. Cohorts were matched for birth weight (±10%), gestational age (±5 days), and fortified feeding. Results: Baseline characteristics were not significantly different: gestational ages 32.8 ± 1.0 versus 33.0 ± 1.2 weeks; birth weights 1900 ± 380 g versus 1840 ± 370 g. Excellent feeding tolerance was demonstrated across >3100 feedings. No necrotizing enterocolitis, abdominal complications, or serious adverse events occurred. Blood glucose, triglycerides, and urea remained normal. Birth weights, lengths, and head circumferences showed no significant differences. Discharge parameters including weight, length, head circumference, and length of stay were also not significantly different. Conclusions: Freeze-dried human milk fortification demonstrates excellent safety and tolerability in preterm infants ≥ 30 weeks gestational age, achieving anthropometric outcomes not significantly different to bovine protein-based fortification. However, the suboptimal protein-to-energy ratio may limit applicability for very low birth weight infants. Therefore, freeze-dried high-temperature short-time pasteurized human milk fortification is suggested to provide appropriate nutritional supplementation for preterm infants with a birth weight over 1500 g.
- Open Access
Standardizing Neonatal Body Composition Assessment Using Air Displacement Plethysmography: Insights from the Bavarian Experience
Background/Objectives: Body composition plays a crucial role in neurodevelopment and the long-term health of preterm and term infants. Air displacement plethysmography (ADP), especially with the PEAPOD® system, is well established in research and increasingly explored in clinical practice. Building on our team’s earlier experiences, this study aimed to (1) evaluate the safety and feasibility of ADP in preterm infants, (2) identify published clinical protocols, and (3) implement and assess a standardized routine—the Bavarian Clinical Protocol (BCP). Methods: We conducted two systematic literature reviews: one on the eligibility-to-assessment rate and safety of ADP in research contexts, and a second focusing on existing clinical protocols. In addition, we retrospectively analyzed routine ADP assessments at the NICU of Nuremberg Children’s University Hospital from January 2022 to December 2024, where the BCP had been introduced. Results: The literature review included 76 studies reporting a total of 8,317 assessments without adverse events. In experimental settings, the eligibility-to-assessment rate was 41%. We identified three published clinical protocols. Following BCP implementation, 626 of 702 eligible infants (89.1%) underwent a total of 851 ADP measurements. No adverse events were observed, and repeated assessments were integrated smoothly into clinical workflows. Conclusions: ADP can be safely and effectively incorporated into neonatal routine care. The Bavarian Clinical Protocol provides a practical framework for standardized application, improves comparability across centers, and supports the clinical use of body composition data to inform individualized nutritional strategies.
Open AccessStandardizing Neonatal Body Composition Assessment Using Air Displacement Plethysmography: Insights from the Bavarian Experience
Background/Objectives: Body composition plays a crucial role in neurodevelopment and the long-term health of preterm and term infants. Air displacement plethysmography (ADP), especially with the PEAPOD® system, is well established in research and increasingly explored in clinical practice. Building on our team’s earlier experiences, this study aimed to (1) evaluate the safety and feasibility of ADP in preterm infants, (2) identify published clinical protocols, and (3) implement and assess a standardized routine—the Bavarian Clinical Protocol (BCP). Methods: We conducted two systematic literature reviews: one on the eligibility-to-assessment rate and safety of ADP in research contexts, and a second focusing on existing clinical protocols. In addition, we retrospectively analyzed routine ADP assessments at the NICU of Nuremberg Children’s University Hospital from January 2022 to December 2024, where the BCP had been introduced. Results: The literature review included 76 studies reporting a total of 8,317 assessments without adverse events. In experimental settings, the eligibility-to-assessment rate was 41%. We identified three published clinical protocols. Following BCP implementation, 626 of 702 eligible infants (89.1%) underwent a total of 851 ADP measurements. No adverse events were observed, and repeated assessments were integrated smoothly into clinical workflows. Conclusions: ADP can be safely and effectively incorporated into neonatal routine care. The Bavarian Clinical Protocol provides a practical framework for standardized application, improves comparability across centers, and supports the clinical use of body composition data to inform individualized nutritional strategies.